Federal Register /Vol. 85, No. 249/Tuesday, December 29 ... · Annexes to this notice, contact [email protected]. SUPPLEMENTARY INFORMATION: A. Background At the direction of

85831 Federal Register / Vol. 85, No. 249 / Tuesday, December 29, 2020 / Notices

28 17 CFR 200.30–3(a)(12).

cautioned that we do not redact or edit personal identifying information from comment submissions. You should submit only information that you wish to make available publicly. All submissions should refer to File Number SR–NYSEARCA–2020–112 and should be submitted on or before January 19, 2021.

For the Commission, by the Division of Trading and Markets, pursuant to delegated authority.28 J. Matthew DeLesDernier, Assistant Secretary. [FR Doc. 2020–28659 Filed 12–28–20; 8:45 am]

BILLING CODE 8011–01–P

SECURITIES AND EXCHANGE COMMISSION

Proposed Collection; Comment Request

Upon Written Request, Copies Available From: Securities and Exchange Commission, Office of FOIA Services, 100 F Street NE, Washington, DC 20549–2736

Extension: Form 2–E, Report pursuant to rule 609 of

Regulation E, SEC File No. 270–222, OMB Control No. 3235–0233

Notice is hereby given that, pursuant to the Paperwork Reduction Act of 1995 (44 U.S.C. 3501 et seq.), the Securities and Exchange Commission (the ‘‘Commission’’) is soliciting comments on the collection of information summarized below. The Commission plans to submit this existing collection of information to the Office of Management and Budget (‘‘OMB’’) for extension and approval.

Rule 609 (17 CFR 230.609) under the Securities Act of 1933 (15 U.S.C. 77a et seq.) requires small business investment companies and business development companies that have engaged in offerings of securities that are exempt from registration pursuant to Regulation E under the Securities Act of 1933 (17 CFR 230.601 to 610a) to report semi- annually on Form 2–E (17 CFR 239.201) the progress of the offering. The form solicits information such as the dates an offering commenced and was completed (if completed), the number of shares sold and still being offered, amounts received in the offering, and expenses and underwriting discounts incurred in the offering. The information provided on Form 2–E assists the staff in monitoring the progress of the offering and in determining whether the offering has stayed within the limits set for an offering exempt under Regulation E.

The Commission estimates that, on average, approximately one respondent submits a Form 2–E filing each year. The Commission further estimates that this information collection imposes an annual burden of four hours and imposes an annual external cost burden of zero.

The collection of information under Form 2–E is mandatory. The information provided by the form will not be kept confidential. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.

Written comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) the accuracy of the agency’s estimate of the burden of the collection of information; (c) ways to enhance the quality, utility, and clarity of the information collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Consideration will be given to comments and suggestions submitted in writing within 60 days of this publication.

Please direct your written comments to David Bottom, Director/Chief Information Officer, Securities and Exchange Commission, c/o Cynthia Roscoe, 100 F Street NE, Washington, DC 20549; or send an email to: [email protected].

Dated: December 22, 2020. Eduardo A. Aleman, Deputy Secretary. [FR Doc. 2020–28769 Filed 12–28–20; 8:45 am]

BILLING CODE 8011–01–P

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

Notice of Product Exclusion Extensions and Additional Modifications: China’s Acts, Policies, and Practices Related to Technology Transfer, Intellectual Property, and Innovation

AGENCY: Office of the United States Trade Representative (USTR). ACTION: Notice of product exclusion extensions and additional modifications.

SUMMARY: In prior notices, the U.S. Trade Representative modified the action in the Section 301 investigation

of China’s acts, policies, and practices related to technology transfer, intellectual property, and innovation by excluding from additional duties certain medical-care products needed to address the COVID–19 outbreak. On March 25, 2020, the U.S. Trade Representative sought public comment on additional modifications in this investigation in order to address COVID–19. This notice announces the U.S. Trade Representative’s determination to extend certain product exclusions and to make further modifications to remove Section 301 duties from additional medical-care products to address COVID–19. DATES: The product exclusion extensions announced in this notice will extend the exclusions through March 31, 2021. The modifications to exclude additional products will apply as of January 1, 2021 until March 31, 2021. U.S. Customs and Border Protection will issue instructions on entry guidance and implementation. FOR FURTHER INFORMATION CONTACT: For general questions about this notice, contact Associate General Counsel Philip Butler, Assistant General Counsels Benjamin Allen or Susie Park Hodge, or Director of Industrial Goods Justin Hoffmann at (202) 395–5725. For specific questions on customs classification or implementation of the product exclusions identified in the Annexes to this notice, contact [email protected]. SUPPLEMENTARY INFORMATION:

A. Background

At the direction of the President, the U.S. Trade Representative imposed additional duties on products of China in order to obtain the elimination of the unfair and damaging acts, policies, and practices identified in this investigation. These additional duties were imposed in four tranches. See 83 FR 28719 (June 20, 2018), 83 FR 40823 (August 16, 2018), 83 FR 47974 (September 21, 2018), as modified by 83 FR 49153 (September 28, 2018), and 84 FR 43304 (August 20, 2019), as modified by 84 FR 69447 and 85 FR 3741.

For each tranche, the U.S. Trade Representative established a process by which U.S. stakeholders could request the exclusion of particular products subject to the action. Additionally, the U.S. Trade Representative later established a process by which U.S. stakeholders could request the extension of particular exclusions.

Throughout the exclusion process, USTR assessed medical necessity in granting exclusions, consistent with its published criteria. In addition, the U.S.

VerDate Sep<11>2014 00:55 Dec 29, 2020 Jkt 253001 PO 00000 Frm 00253 Fmt 4703 Sfmt 4703 E:\FR\FM\29DEN1.SGM 29DEN1KH

AM

MO

ND

on

DS

KJM

1Z7X

2PR

OD

with

NO

TIC

ES

mailto:[email protected]




Trade Representative, in consultation with the Department of Health and Human Services (HHS), prioritized the review and exclusion of requests addressing medical-care products related to the U.S. response to COVID– 19. See 85 FR 13970 (March 10, 2020), 85 FR 15015 (March 16, 2020), and 85 FR 15244 (March 17, 2020). These exclusions covered personal protective equipment products and other medical- care related products.

On March 25, 2020, in order to reflect developments in the efforts to respond to COVID–19, the U.S. Trade Representative requested public comments on possible further modifications to remove Section 301 duties from additional medical-care products to address the COVID–19 outbreak. 85 FR 16987 (March 25, 2020). This docket was open from March 25– June 25, 2020, and each commenter was required to identify the particular product of concern and explain how it relates to the response to COVID–19. USTR accepted comments regarding any product covered by the action in the

investigation, regardless of whether the product was subject to a pending or denied exclusion request.

B. Determination To Extend Certain Exclusions and Make Additional Modifications

In light of the rising spread and ongoing efforts to combat COVID–19, the U.S. Trade Representative has determined that maintaining or re- imposing additional duties on certain products subject to the action no longer is appropriate and that the application of additional duties to these products could impact U.S. preparedness to address COVID–19.

Pursuant to sections 301(b), 301(c), and 307(a) of the Trade Act of 1974, as amended, and in accordance with the advice of the interagency Section 301 Committee, the U.S. Trade Representative has determined to extend certain product exclusions on medical-care products and to remove the duties from additional medical-care products. The medical-care products covered by this determination are set out in the annexes to this notice. In light

of the evolving nature of the battle against COVID–19, the U.S. Trade Representative has determined to extend the exclusions in the annexes until March 31, 2021, and the modifications will be effective from January 1, 2021, to March 31, 2021. The U.S. Trade Representative may consider further extensions and/or additional modifications as appropriate. The U.S. Trade Representative’s determination also takes into account advice from advisory committees and any public comments.

The exclusions and modifications are available for any product that meets the description in the Annexes. Further, the scope of each exclusion and modification is governed by the scope of the ten-digit Harmonized Tariff Schedule of the United States (HTSUS) subheadings and product descriptions in the annexes to this notice.

Joseph Barloon, General Counsel, Office of the United States Trade Representative. BILLING CODE 3290–F0–P

VerDate Sep<11>2014 00:55 Dec 29, 2020 Jkt 253001 PO 00000 Frm 00254 Fmt 4703 Sfmt 4703 E:\FR\FM\29DEN1.SGM 29DEN1KH

AM

MO

ND

on

DS

KJM

1Z7X

2PR

OD

with

NO

TIC

ES


VerDate Sep<11>2014 00:55 Dec 29, 2020 Jkt 253001 PO 00000 Frm 00255 Fmt 4703 Sfmt 4725 E:\FR\FM\29DEN1.SGM 29DEN1 EN

29D

E20

.415

</G

PH

>

KH

AM

MO

ND

on

DS

KJM

1Z7X

2PR

OD

with

NO

TIC

ES



29D

E20

.416

</G

PH

>

KH

AM

MO

ND

on

DS

KJM

1Z7X

2PR

OD

with

NO

TIC

ES



29D

E20

.417

</G

PH

>

KH

AM

MO

ND

on

DS

KJM

1Z7X

2PR

OD

with

NO

TIC

ES



29D

E20

.418

</G

PH

>

KH

AM

MO

ND

on

DS

KJM

1Z7X

2PR

OD

with

NO

TIC

ES



29D

E20

.419

</G

PH

>

KH

AM

MO

ND

on

DS

KJM

1Z7X

2PR

OD

with

NO

TIC

ES



29D

E20

.420

</G

PH

>

KH

AM

MO

ND

on

DS

KJM

1Z7X

2PR

OD

with

NO

TIC

ES



29D

E20

.421

</G

PH

>

KH

AM

MO

ND

on

DS

KJM

1Z7X

2PR

OD

with

NO

TIC

ES



29D

E20

.422

</G

PH

>

KH

AM

MO

ND

on

DS

KJM

1Z7X

2PR

OD

with

NO

TIC

ES



29D

E20

.423

</G

PH

>

KH

AM

MO

ND

on

DS

KJM

1Z7X

2PR

OD

with

NO

TIC

ES



29D

E20

.424

</G

PH

>

KH

AM

MO

ND

on

DS

KJM

1Z7X

2PR

OD

with

NO

TIC

ES



29D

E20

.425

</G

PH

>

KH

AM

MO

ND

on

DS

KJM

1Z7X

2PR

OD

with

NO

TIC

ES



29D

E20

.426

</G

PH

>

KH

AM

MO

ND

on

DS

KJM

1Z7X

2PR

OD

with

NO

TIC

ES



29D

E20

.427

</G

PH

>

KH

AM

MO

ND

on

DS

KJM

1Z7X

2PR

OD

with

NO

TIC

ES


[FR Doc. 2020–28780 Filed 12–28–20; 8:45 am]

BILLING CODE 3290–F0–C

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

[Docket No. FAA–2020–1199; Airspace Docket No. 20–AEA–21]

Notice of Availability of Written Re- Evaluation and Record of Decision; New York/New Jersey/Philadelphia Metropolitan Area Airspace Redesign

AGENCY: Federal Aviation Administration (FAA), DOT. ACTION: Notice.

SUMMARY: The Federal Aviation Administration (FAA) announces the availability of a Written Re-evaluation and Record of Decision (WR/ROD) for the New York/New Jersey/Philadelphia (NY/NJ/PHL) Metropolitan Area Airspace Redesign project. This 2020 WR/ROD follows the issuance of a Final Environmental Impact Statement (EIS) for the project, issued in July 2007, and a subsequent ROD (September 2007) that approved the Integrated Airspace Alternative with Integrated Control

Complex for implementation. The September 2007 ROD was followed by a corrected ROD (October 2007), as well as a WR/ROD (July 2008) that re- affirmed the original decision in light of new schedule limits at John F. Kennedy International Airport (JFK) and Newark Liberty International Airport (EWR). DATES: The FAA’s WR/ROD for the NY/ NJ/PHL Metropolitan Airspace Redesign is effective December 22, 2020. FOR FURTHER INFORMATION CONTACT: For additional information, contact Matthew Cathcart, Acting Manager, Operations Support Group, in writing to Federal Aviation Administration, Eastern Service Center, Operations Support Group, AJV–E2, FAA Southern Regional Office, P.O. Box 20636, Atlanta, GA 30320; by telephone, at (404) 305–5624; or, by electronic mail, at [email protected]. SUPPLEMENTARY INFORMATION: The purpose of the NY/NJ/PHL Metropolitan Area Airspace Redesign project was to increase the efficiency and reliability of the airspace structure and the Air Traffic Control (ATC) system, thereby accommodating growth while enhancing safety and reducing delays in air travel for the NY/NJ/PHL

Metropolitan Area. The Airspace Redesign project was intended to modernize the structure of the NY/NJ/ PHL air traffic environment while laying a foundation for achieving the Next Generation Air Transportation System (NextGen) in an environmentally responsible manner.

While four stages of implementation were originally planned, FAA paused the project in 2012 in light of air transportation system changes in the intervening years. While several beneficial elements of the project were implemented, the National Airspace System evolved significantly between the 2007 EIS and 2012. New NextGen capabilities, such as Time Based Metering and advanced satellite based navigation procedures, and increasing consolidation of the airline industry, changes in system use, and evolving traffic projections resulted in new and different airspace and procedures requirements. As a result, the FAA suspended the Airspace Redesign project in May 2013. The FAA has determined it is appropriate to end implementation and has prepared the aforementioned December 2020 WR/ ROD. The WR/ROD may be accessed on the FAA’s public website: https://


29D

E20

.428

</G

PH

>

KH

AM

MO

ND

on

DS

KJM

1Z7X

2PR

OD

with

NO

TIC

ES


https://www.faa.gov/air_traffic/nas/nynjphl_redesign/documentation/

Documents

Federal Register /Vol. 85, No. 249/Tuesday, December 29 ... · Annexes to this notice, contact [email protected]. SUPPLEMENTARY INFORMATION: A. Background At the direction of